SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Cannabis Stocks Today — Thursday 7 May 2026: Curaleaf Leads +9.4% as Sector Rallies

    By

    US multi-state operators ripped higher on Wednesday, with CURLF jumping more than 9% to lead a broad cannabis rally that pushed the BoC Cannabis Index up +1.67%. Pharma name JAZZ added 7.68% on heavy volume, while every cannabis ETF in the index — MSOS, CNBS, MJ and YOLO — closed firmly in the green. The session marked one of the broadest single-day advances in the BoC universe in recent weeks.

    Breadth told the story: 27 of 38 tracked names finished higher, against just nine decliners and two flat sessions. US multi-state operators were the standout cohort, with CURLF, GTBIF, JUSHF, TCNNF, CRLBF and AAWH all advancing in unison — a rare bit of uniformity for a group that has spent most of 2026 trading independently of one another. Canadian licensed producers also caught a bid, as Aurora Cannabis (+2.91%), Tilray (+1.23%) and Canopy Growth (+6.48%) joined the move, and ancillaries SMG (+4.65%) and GRWG (+4.58%) tracked higher with the operators. The clear pocket of weakness sat in cannabis-adjacent income names — REIT IIPR, lender AFCG and tobacco/alcohol majors MO and ABBV all finished lower, with REFI and OGI essentially flat on the day.

    Ticker Price Change ($) Change (%)
    CURLF $3.81 +$0.328 +9.43%
    JAZZ $228.57 +$16.31 +7.68%
    CGC $1.15 +$0.07 +6.48%
    VEXTF $0.253 +$0.013 +5.42%
    HITI $2.49 +$0.12 +5.06%
    SMG $62.85 +$2.79 +4.65%
    GRWG $1.37 +$0.06 +4.58%
    MSOS $5.27 +$0.23 +4.56%
    CNBS $30.57 +$1.10 +3.73%
    IXHL $4.91 +$0.16 +3.37%
    JUSHF $0.5251 +$0.0156 +3.06%
    GTBIF $8.34 +$0.24 +2.96%
    ACB $3.54 +$0.1 +2.91%
    AYRWF $0.0127 +$0.0003 +2.42%
    CRBP $10.92 +$0.25 +2.34%
    EEX $4.60 +$0.1 +2.22%
    MJ $27.96 +$0.59 +2.16%
    YOLO $3.24 +$0.0627 +1.97%
    AAWH $0.5705 +$0.0107 +1.91%
    STZ $152.29 +$2.49 +1.66%
    TLRY $5.76 +$0.07 +1.23%
    CBWTF $0.1025 +$0.0012 +1.18%
    TCNNF $9.79 +$0.1 +1.03%
    SNDL $1.44 +$0.01 +0.70%
    CRLBF $1.10 +$0.0059 +0.54%
    MAPS $0.3496 +$0.0016 +0.46%
    TPB $81.26 +$0.31 +0.38%
    OGI $1.39 +$0 +0.00%
    REFI $12.25 +$0 +0.00%
    CRON $2.62 $-0.01 -0.38%
    ABBV $205.03 $-1.08 -0.52%
    IPW $0.831 $-0.009 -1.07%
    VFF $2.69 $-0.05 -1.82%
    GLASF $9.50 $-0.22 -2.26%
    AFCG $2.77 $-0.08 -2.81%
    MO $70.17 $-2.62 -3.60%
    IMCC $0.2565 $-0.0098 -3.68%
    IIPR $57.70 $-2.62 -4.34%

    Curaleaf was the day’s top gainer, closing at $3.81 for a +9.43% gain on no immediate news catalyst — the move arrived alongside a strong session for the broader US MSO cohort and follows weeks of consolidation in the name. Jazz Pharmaceuticals’ 7.68% pop was the other clear standout, while sympathy bids lifted Canopy Growth (+6.48%), Vext Science (+5.42%) and High Tide (+5.06%) past the 5% mark. The downside was led by Innovative Industrial Properties, which fell -4.34% to $57.70 as the cannabis REIT diverged sharply from the operator names it lends against — IIPR now sits noticeably below its recent range, alongside Altria (-3.60%) and AFC Gamma (-2.81%).

    Worth noting on ETF flows: MSOS (+4.56%) outpaced the broader-mandate MJ (+2.16%), reflecting today’s MSO leadership over the wider Canadian-heavy basket. Two index constituents — HMMJ.TO and VRNOF — are tracked but excluded from today’s calculation (HMMJ.TO sits behind a Finnhub data tier; VRNOF returned no print). Track all cannabis stocks live on the Business of Cannabis Stocks Tracker.

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Rob Dale

    Rob runs technical and SEO strategy at Business of Cannabis and has a Master’s in Clinical Exercise Physiology. He blends search know-how with a solid grasp of clinical methods to spot what actually matters in new studies and regulations. Day to day, he helps shape evidence-based explainers and features, translating data into clear, useful insights for industry pros.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free